Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Obalon Therapeutics Inc. (OBLN)

1.68   0.05 (3.07%) 10-11 16:00
Open: 1.68 Pre. Close: 1.63
High: 1.7 Low: 1.61
Volume: 199,951 Market Cap: 10M
Obalon Therapeutics Inc is a commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.704 - 1.715 1.715 - 1.725
Low: 1.583 - 1.597 1.597 - 1.61
Close: 1.658 - 1.68 1.68 - 1.701

Technical analysis

as of: 2019-10-11 4:33:39 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 2.38     One year: 2.74
Support: Support1: 1.53    Support2: 1.27
Resistance: Resistance1: 2.04    Resistance2: 2.35
Pivot: 1.88
Moving Average: MA(5): 1.69     MA(20): 1.95
MA(100): 4.97     MA(250): 11.30
MACD: MACD(12,26): -0.22     Signal(9): -0.23
Stochastic oscillator: %K(14,3): 11.96     %D(3): 8.61
RSI: RSI(14): 35.78
52-week: High: 34.00  Low: 1.53  Change(%): -92.9
Average Vol(K): 3-Month: 69331  10-Days: 99439

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
OBLN has closed above bottom band by 21.7%. Bollinger Bands are 84.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to OBLN's normal range. The bands have been in this narrow range for 38 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 03 Oct 2019 20:00:47 +0000
Health Care Sector Update for 10/03/2019: MIST,ACB,ACB.TO,OBLN,MESO

Thu, 03 Oct 2019 17:25:41 +0000
Health Care Sector Update for 10/03/2019: ACB,OBLN,MESO

Wed, 07 Aug 2019 09:56:26 +0000
Guardant In Good Health, GW Pharma On Track, FLXN Abuzz

Wed, 31 Jul 2019 05:25:21 +0000
5 Top Losers In Healthcare Sector (RMTI, LGND, MIST...)

Thu, 30 May 2019 22:17:08 +0000
5 Top Gainers In Pharma Sector (BCRX, NOVN, TOCA...)

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 5.99
Shares Float (M) 1.84
% Held by Insiders 11.00
% Held by Institutions 56.41
Shares Short (K) 63
Shares Short P. Month (K)

Stock Financials

EPS -13.267
Book Value (p.s.) 2.380
PEG Ratio
Profit Margin
Operating Margin -399.62
Return on Assets (ttm) -69.4
Return on Equity (ttm) -250.1
Qtrly Rev. Growth -85.9
Gross Profit (p.s.) 0.614
Sales Per Share
EBITDA (p.s.) -4.699
Qtrly Earnings Growth
Operating Cash Flow (M) -24.71
Levered Free Cash Flow (M) -13.98

Stock Valuations

P/E -0.13
P/E Growth Ratio 0.03
P/BV 0.71
P/S 3225384.50
P/CF -0.41

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2019-07-25
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.